Dear Friend,

This year Democracy Now! is celebrating our 25th anniversary—that's 25 years of bringing you fearless, independent reporting. Since our very first broadcast in 1996, Democracy Now! has refused to take government or corporate funding, because nothing is more important to us than our editorial independence. But that means we rely on you, our audience, for support. If everyone who tunes into Democracy Now! signed up for a monthly donation of just $10, we could cover our operating costs for the entire year. Please do your part today. Right now, a generous donor will even TRIPLE your first monthly gift, which means it’ll go three times as far! This is a challenging time for us all, but if you're able to start a new monthly donation, please don’t delay. We’re counting on your support. Thank you and remember, wearing a mask is an act of love.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

Pressure Mounts on Germany to Support COVID-19 Patent Waiver as WTO Panel Meets

HeadlineSep 14, 2021

Meanwhile, more than 140 Nobel laureates and former heads of state have signed an open letter calling on Germany to support a waiver of intellectual property rights for COVID vaccines. Their call comes as a World Trade Organization panel is set to convene this week to discuss a patent waiver — nearly a year after India and South Africa proposed the move, which would require the unanimous consent of all 164 WTO member nations. A handful of countries, led by Germany and the United Kingdom, have so far refused to agree to a patent waiver. Joining the call for a People’s Vaccine is California Democratic Congressmember Ro Khanna.

Rep. Ro Khanna: “This issue is so fundamental. If you believe that every human life has dignity and has moral worth, then we need to ensure that everyone has access to this vaccine. And a first step to getting people access to the vaccine is making sure that we’re sharing the know-how of how they can build it.”

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top